http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0504046-B8
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb1194dacc72db825441b031a11252b8 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
| filingDate | 2005-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c6a7c792fd1bff546d83bca75b5632 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f208b633ff6afedb3fd7724a843bd4bb |
| publicationDate | 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0504046-B8 |
| titleOfInvention | pharmaceutical composition of controlled release of mebeverine containing polycarbophil, use of a pharmaceutical composition and tablet containing mebeverine of reduced dimensions |
| abstract | controlled release pharmaceutical composition, use of a pharmaceutical composition, method to treat the symptoms of irritable bowel syndrome and reduced size tablet the present invention relates to controlled release pharmaceutical formulations containing (a) at least one antispasmodic agent and (b) ) at least one non-soluble semi-synthetic fiber, in combination with controlled release agents, intended for use in the treatment of symptoms associated with irritable bowel syndrome. |
| priorityDate | 2005-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4031 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501546 |
Total number of triples: 16.